<?php
include 'includes/lib.php';
printHeader(array(
	'title' => 'Conference 2010 | Scientific Program',
	'page_nav_id' => 'program',
	'css' => 'dt { font-weight: bold; margin: 0.7em 0 0.2em 0 }',
));
?>

<?php include 'includes/conference-title.inc.php' ?>

<?php include 'includes/menu.inc.php' ?>

<h2>Scientific Program</h2>

<p>This year we want to implement a novel presentation style for our meeting in Seattle to make it more like a <strong>LARGE LAB MEETING</strong>. The goal is to facilitate discussion on focused topics and clearly define what is known, what is not, and what the next steps ought to be.</p>

<p>The oral presentations at this year's meeting will be organized under specific questions. The potential session questions, along with a sample of the type of data that would be relevant, are listed below.  All presentations in each session must make a clear contribution to answering that session's question.  For each oral session, we plan to have a mixture of short (5-10 minutes) and long (15-20 minutes) talks, depending on the amount of relevant data to be presented.  Posters will also be grouped according to these specific questions. </p>

<?php include 'includes/abstracts-menu.inc.php' ?>

<!--<h3>Session Topics</h3>

<p class="note">Talks will be assigned to one or more of the following sessions.</p>

<dl>
<dt>Session I: What does dysferlin look like? </dt>

<dd>Examples: Dysferlin molecular structure by EM or crystallography; chemical modifications; domain structure; etc. </dd>

<dt>Session II:  Where is dysferlin localized? </dt>

<dd>Examples: Sub-cellular location (e.g. surface, vesicles, t-tubules); trafficking; changes in sub-cellular location in response to injury or other perturbations; kinetics of location changes; expression in different cell types; etc.  </dd>

<dt>Session III:  What does dysferlin do? </dt>

<dd>Examples: Dysferlin's role in membrane repair, vesicle fusion, secretion, exo/endocytosis, etc. </dd>

<dt>Session IV:  What do dysferlin’s partners do? </dt>

<dd>Examples: Identification of interacting proteins; conditions under which the interaction takes place; role of the interacting proteins; role of other ferlin proteins (e.g. myoferlin, otoferlin); etc.  </dd>

<dt>Session V:  What does dysferlin-deficient muscle look like? </dt>

<dd>Examples: Imaging of muscle sections; characterization of muscle membrane defects; comparison of number and location of intracellular vesicles; T-tubule structure; etc. </dd>

<dt>Session VI:  What is the role of inflammation in dysferlinopathy? </dt>

<dd>Examples: Characterization of the dysferlin-deficient inflammatory response; contribution of inflammation to pathology; role of dysferlin in immune cells; etc. </dd>

<dt>Session VII:  Is there a regeneration defect in dysferlinopathy? </dt>

<dd>Examples: Ex vivo characterization of myoblast fusion, proliferation; in vivo assays for myoblast fusion, stem cell turnover; role of dysferlin in regeneration (e.g. fusion, signaling); etc. </dd>

<dt>Session VIII:  How can we compensate for dysferlin’s absence? </dt>

<dd>Examples: Activation of other proteins; drug treatments; modulation of calcium pathways; myostatin inhibition; etc. </dd>

<dt>Session IX:  How can we put dysferlin back into muscle? </dt>

<dd>Examples: Gene therapy, viral or non-viral; gene editing; stem cell therapy; etc. </dd>

<dt>Session X:  What tools are available for dysferlin research? </dt>

<dd>Examples: Dysferlin-specific assays; cell lines; animal models; antibodies; databases; diagnostic tools; etc.</dd>
</dl>-->

<h3>Meeting Schedule</h3>

<div class="schedule">
<h4 class="day">SATURDAY, Sept 11</h4>

<p class="event">
<span class="time">1:00 - 2:00 PM</span>
<span class="name">Registration - the Regency Ballroom</span>
</p>

<p class="event">
<span class="time">2:00 - 2:30 PM</span>
<span class="name">Welcome to the 4th annual Jain Foundation Conference on Dysferlinopathy<br>Akshay Jain and Plavi Mittal</span>
</p>

<p class="session">
<span class="time">2:30 - 3:30 PM</span>
<span class="name">Session I: What does dysferlin look like?</span>
<span class="desc">Intro: Garg, <span class="speakers">Speakers: Sutton, Cooper</span><br>Discussion I</span>
</p>

<p class="session">
<span class="time">3:30 - 4:40 PM</span>
<span class="name">Session II: Where is dysferlin localized?</span>
<span class="desc">Intro: Williams, <span class="speakers">Speakers: Bloch, Laval, Cooper, Butler-Browne</span><br>Discussion II</span>
</p>

<p class="event">
<span class="time">4:40 - 4:50 PM</span>
<span class="name">Break</span>
</p>

<p class="session">
<span class="time">4:50 - 6:15 PM</span>
<span class="name">Session III: What happens when dysferlin is missing?</span>
<span class="desc">Intro: Monnier, <span class="speakers">Speakers: Grounds, Williams, Bloch, Maguire, Spuler</span><br>Discussion III</span>
</p>

<p class="event">
<span class="time">6:15 - 7:00 PM</span>
<span class="name">Patient Perspectives</span>
</p>

<p class="event">
<span class="time">7:30 - 11:00 PM</span>
<span class="name">Reception - Maggiano's Little Italy</span>
</p>

<h4 class="day">SUNDAY, Sept 12</h4>

<p class="event">
<span class="time">7:00 - 8:00 AM</span>
<span class="name">Breakfast - Regency Ballroom</span>
</p>

<p class="session">
<span class="time">8:00 - 10:10 AM</span>
<span class="name">Session IV: What does dysferlin do?</span>
<span class="desc">Intro: Albrecht, <span class="speakers">Speakers: Bloch, Barton, Cooper, Spuler, Richard, Vogel, Blank, McNally</span><br>Discussion IV</span>
</p>

<p class="event">
<span class="time">10:10 - 10:20 AM</span>
<span class="name">Break</span>
</p>

<p class="session">
<span class="time">10:20 - 11:40 AM</span>
<span class="name">Session V: What do dysferlin partners do?</span>
<span class="desc">Intro: Rufibach, <span class="speakers">Speakers: van der Maarel, Bloch, Bashir</span><br>Discussion V</span>
</p>

<p class="event">
<span class="time">11:40 - 12:00 PM</span>
<span class="name">Jain Foundation Initiatives</span>
</p>

<p class="event">
<span class="time">12:00 - 1:00 PM</span>
<span class="name">Lunch - Regency Ballroom</span>
</p>

<p class="session">
<span class="time">1:00 - 3:20 PM</span>
<span class="name">Session VI: What is the role of inflammation in dysferlinopathy?</span>
<span class="desc">Intro: Garg, <span class="speakers">Speakers: Hoffman, Roche, Gallardo, Laval, Spuler, Han</span><br>Discussion VI</span>
</p>

<p class="event">
<span class="time">3:20 - 6:00 PM</span>
<span class="name">Poster Session I - Regency Ballroom</span>
</p>

<h4 class="day">MONDAY, Sept 13</h4>

<p class="event">
<span class="time">7:00 - 8:00 AM</span>
<span class="name">Breakfast - Regency Ballroom</span>
</p>

<p class="session">
<span class="time">8:00 - 9:30 AM</span>
<span class="name">Session VII: Is there a regeneration defect in dysferlinopathy?</span>
<span class="desc">Intro: Albrecht, <span class="speakers">Speakers: Cohen, Laval, Bloch, Richard</span><br>Discussion VII</span>
</p>

<p class="event">
<span class="time">9:30 - 9:40 AM</span>
<span class="name">Break</span>
</p>

<p class="session">
<span class="time">9:40 - 11:50 AM</span>
<span class="name">Session VIII: How do we put dysferlin back?</span>
<span class="desc">Intro: Mittal, <span class="speakers">Speakers: Levy, Bartoli, Richard, Hirsch, Diaz-Mannera, Calos</span><br>Discussion VIII</span>
</p>

<p class="event">
<span class="time">11:50 - 12:50 PM</span>
<span class="name">Lunch - Regency Ballroom</span>
</p>

<p class="session">
<span class="time">12:50 - 4:00 PM</span>
<span class="name">Session IX: How do we compensate for dysferlin's absence?</span>
<span class="desc">Intro: Albrecht, <span class="speakers">Speakers: Molkentin, Hoffman, Weisleder, Zimmerberg, Sweeney, Serafini, Sonneman, Duong, Authier</span><br>Discussion IX</span>
</p>

<p class="event">
<span class="time">4:00 - 6:00 PM</span>
<span class="name">Poster Session II - Regency Ballroom</span>
</p>

<p class="event">
<span class="time">6:30 - 10:30 PM</span>
<span class="name">Gala Dinner - Meet in lobby at 6:15 for Bus to the Gala Dinner</span>
</p>

<h4 class="day">TUESDAY, Sept 14</h4>

<p class="event">
<span class="time">7:00 - 8:00 AM</span>
<span class="name">Breakfast - Regency Ballroom</span>
</p>

<p class="session">
<span class="time">8:00 - 9:20 AM</span>
<span class="name">Session X: What's new in diagnostic tools for dysferlinopathy?</span>
<span class="desc">Intro: Rufibach, <span class="speakers">Gallardo, Krahn, Mahjneh</span><br>Discussion X</span>
</p>

<p class="event">
<span class="time">9:20 - 10:00 AM</span>
<span class="name">Closing Remarks . Jain Foundation</span>
</p>

<p class="event">
<span class="time">11:00 - 12:00 PM</span>
<span class="name">Lunch - (Boxed) - Regency Ballroom</span>
</p>
</div>

<h3>Confirmed Attendees</h3>

<table>
<tr><th>Confirmed Attendee</th> <th>Institution</th></tr>
<tr><td>Florian Barthelemy</td>
<td>Universite de la Mediterranee-Marseille cedex 05, France</td></tr>
<tr><td>Marc Bartoli</td>
<td>Universite de la Mediterranee-Marseille cedex 05, France</td></tr>
<tr><td>Rumaisa Bashir</td>
<td>University of Durham-Durham, UK</td></tr>
<tr><td>Pascal Bernatchez</td>
<td>University of British Columbia/St. Paul's Hospital-Vancouver, B.C.  Canada</td></tr>
<tr><td>Bob Bloch</td>
<td>University of Maryland School of Medicine-Baltimore, MD</td></tr>
<tr><td>Perrine Borel</td>
<td>Genethon- Evry, France</td></tr>
<tr><td>Bob Brown</td>
<td>U MA Medical School-Worcester, MA</td></tr>
<tr><td>Gillian Butler-Browne</td>
<td>Institut de Myologie, Paris, France</td></tr>
<tr><td>Michele Calos</td>
<td>Stanford University School of Medicine-Stanford, CA</td></tr>
<tr><td>Jeff Chamberlain</td>
<td>University of Washington, Seattle, WA</td></tr>
<tr><td>Tatiana Cohen</td>
<td>Children's National Medical Center- Washington, D.C.</td></tr>
<tr><td>Sandra Cooper</td>
<td>The Children's Hospital at Westmead- Sydney, New South Wales, Australia</td></tr>
<tr><td>Annamaria De Luca</td>
<td>University of Bari-Bari, Italy</td></tr>
<tr><td>Antoine de Morrée</td>
<td>Leiden University Medical Center-Leiden, Netherlands</td></tr>
<tr><td>Alexis Demonbreun</td>
<td>University of Chicago-Chicago, IL</td></tr>
<tr><td>Jordi Diaz-Manera</td>
<td>Neurology Department. Hospital de la Santa Creu i Sant Pau-Barcelona, Spain</td></tr>
<tr><td>Kerry Fuson</td>
<td>Texas Tech University Health Sciences Center-Lubbock, TX</td></tr>
<tr><td>Eduard Gallardo</td>
<td>Neurology Department. Hospital de la Santa Creu i Sant Pau-Barcelona, Spain</td></tr>
<tr><td>Miranda Grounds</td>
<td>University of Western Australia-Crawley, WA, Australia</td></tr>
<tr><td>Renzhi Han</td>
<td>Loyola Univeristy Medical Center-Maywood, IL</td></tr>
<tr><td>Matt Hirsch</td>
<td>University of North Carolina-Chapel Hill, NC</td></tr>
<tr><td>Bradley Hodges</td>
<td>Prothelia Inc.- Milford, MA</td></tr>
<tr><td>Eric Hoffman</td>
<td>Children's National Medical Center- Washington, D.C.</td></tr>
<tr><td>Akshay Jain</td>
<td>Jain Foundation, Inc.-Seattle, WA</td></tr>
<tr><td>Tom Kirchhausen</td>
<td>Harvard Medical School-Boston, MA</td></tr>
<tr><td>Rinse Klooster</td>
<td>Leiden University Medical Center-Leiden, Netherlands</td></tr>
<tr><td>Martin Krahn</td>
<td>Université de la Méditerranée-Marseille, France</td></tr>
<tr><td>Pradeeo Gonugunta Kumar</td>
<td>Nizam's Institute of Medical Sciences- Andhra Pradesh, India</td></tr>
<tr><td>Steve Laval</td>
<td>Newcastle University-Newcastle-upon-Tyne, Tyne and Wear  UK</td></tr>
<tr><td>Angela Lek</td>
<td>Institute for Neuroscience and Muscle Research- Westmead, NSW Australia</td></tr>
<tr><td>Monkel Lek</td>
<td>Institute for Neuroscience and Muscle Research- Westmead, NSW Australia</td></tr>
<tr><td>Cleo Leung</td>
<td>UBC James Hogg Research Centre, Providence Heart+Lung Institute- Vancouver, B.C.  Canada</td></tr>
<tr><td>Nicolas Lévy</td>
<td>INSERM-Marseille, France</td></tr>
<tr><td>William Lostal</td>
<td>GENETHON-Evry, France</td></tr>
<tr><td>Jianje Ma</td>
<td>TRIM-edicine- North Brunswick, NJ</td></tr>
<tr><td>Ibrahim</td>
<td>University of Oulu-Oulu, Finland</td></tr>
<tr><td>Elizabeth McNally</td>
<td>University of Chicago- Chicago, IL</td></tr>
<tr><td>Jeff Molkentin</td>
<td>Cincinnati Children's Hospital Medical Center- Cincinnati, OH</td></tr>
<tr><td>François Monjaret</td>
<td>Genethon- Evry, France</td></tr>
<tr><td>Vincent Mouly</td>
<td>Institut de Myologie- Paris, France</td></tr>
<tr><td>Maura Parker</td>
<td>Fred Hutchinson Cancer Research Center-Seattle, WA</td></tr>
<tr><td>Terry Partridge</td>
<td>Children's National Medical Center-Washington, D.C.</td></tr>
<tr><td>Peter Pytel</td>
<td>University of Chicago-Chicago, IL</td></tr>
<tr><td>Usha Ramachandran</td>
<td>University of Durham-Durham, UK</td></tr>
<tr><td>Wendy Resneck</td>
<td>University of Maryland-Baltimore, MD</td></tr>
<tr><td>Isabelle Richard</td>
<td>Genethon- Evry, France</td></tr>
<tr><td>John Robinson</td>
<td>Ohio State University- Columbus, OH</td></tr>
<tr><td>Joseph Roche</td>
<td>University of Maryland-Baltimore, MD</td></tr>
<tr><td>Peter Sazani</td>
<td>AVI BioPharma-Bothell, WA</td></tr>
<tr><td>Kevin Sonnemann</td>
<td>University of Wisconsin-Madison, WI</td></tr>
<tr><td>Simone Spuler</td>
<td>Charité Medical Faculty-Berlin, Deutschland</td></tr>
<tr><td>Daniel Stockholm</td>
<td>Genethon- Evry, France</td></tr>
<tr><td>Bryan Sutton</td>
<td>Texas Tech University Health Sciences Center-Lubbock, TX</td></tr>
<tr><td>Lee Sweeney</td>
<td>Univ. of Penn. School of Medicine, Philadelphia, PA</td></tr>
<tr><td>Silvere van der Maarel</td>
<td>Leiden University Medical Center-Leiden, Netherlands</td></tr>
<tr><td>Steven Vogel</td>
<td>NIAAA/NIH-Rockville, MD</td></tr>
<tr><td>Barbara Wakimoto</td>
<td>Univeristy of Washington- Seattle, WA</td></tr>
<tr><td>Noah Weisleder</td>
<td>TRIM-edicine- North Brunswick, NJ</td></tr>
<tr><td>Zipora Yablonka-Reuveni</td>
<td>University of Washington School of Medicine-Seattle, WA</td></tr>
<tr><td>Joshua Zimmerberg</td>
<td>NICHD, NIH-Bethesda, MD</td></tr>
</table>

<?php
	printFooter();
?>
